MYRIAD GENETICS, INC. Long-Term Debt
MYRIAD GENETICS, INC. (MYGN) had Long-Term Debt of $120.70 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-07-31
- 2026-06-30: Long-term Debt, Excluding Current Maturities $120.70M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $120.30M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $119.90M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $119.50M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $120.70M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $120.30M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $119.90M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $119.50M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $59.30M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $39.60M 10-K · filed 2026-02-24 |
| 2024-09-30 | $39.00M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $38.80M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $38.70M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $38.50M 10-K · filed 2025-02-28 |
| 2023-09-30 | $38.50M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $38.40M 10-Q · filed 2023-08-04 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 |
| 2020-12-31 | $224.80M 10-K · filed 2022-02-25 |
| 2020-06-30 | $224.40M 10-K · filed 2020-08-13 |
| 2020-03-31 | $225.20M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $225.10M 10-Q · filed 2020-02-07 |
| 2019-09-30 | $225.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $233.50M 10-K · filed 2020-08-13 |
| 2019-03-31 | $263.40M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $273.30M 10-Q · filed 2019-02-06 |
| 2018-09-30 | $258.00M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $9.30M 10-K · filed 2019-08-13 |
| 2018-03-31 | $69.30M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $43.20M 10-Q · filed 2018-02-07 |
| 2017-06-30 | $99.10M 10-K · filed 2018-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |